<?xml version="1.0" encoding="UTF-8"?>
<p>A first bioactivity screening was carried out on extracts at the fixed concentration of 50 μg/mL. The obtained results (
 <xref rid="t0001" ref-type="table">Table 1</xref>) allowed the selection of eleven extracts, whose IA was higher than 30%, namely: 
 <italic>Camellia sinensis</italic> Kuntze (leaves) (CCS), 
 <italic>Ceterach officinarum</italic> D.C. (aerials parts) (COF), 
 <italic>Cinnamomum zeylanicum</italic> Nees (barks) (CZE), 
 <italic>Ginkgo biloba</italic> L. (leaves) (GBI), 
 <italic>Glycyrrhiza glabra</italic> L.(roots) (GGL), 
 <italic>Rheum officinale</italic> Baill. (rhizomes) (ROF), 
 <italic>Rhodiola rosea</italic> L. (roots) (RRO), 
 <italic>Ribes nigrum</italic> L. (leaves) (RNI), 
 <italic>Salvia officinalis</italic> L. (leaves) (SOF), 
 <italic>Tilia platyphyllos</italic> Scop. (aerial parts) (TPL) and 
 <italic>Vitis vinifera</italic> L. (leaves) (VVI). Among them, four resulted active against both enzymes (CSI, GBI, RRO, VVI), five showed Tyr IA only (GGL, RNI, ROF, SOF, TPL), and two only Ela IA (COF, CZE).
</p>
